Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for Metabolic Syndrome Microvascular Flow
NCT00666029Phase 2Completed
- Sponsor
- University Hospital Southampton NHS Foundation Trust
- Start
- Feb 2006
- Primary completion
- Feb 2008
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in metabolic syndrome comparing Atorvastatin with Placebo (2 arms). Primary endpoints: Muscle Microvascular Function at 6 months and Insulin Sensitivity Index at 6 months. Started Feb 2006; status: completed.
02
Drugs
atorvastatin
03
Conditions
metabolic syndrome
Beyond the preview
Go deeper on NCT00666029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00666029.